Considerations in reperfusion therapy of elderly patients with ST elevation acute myocardial infarction

Edward L. Portnay, Alan K Berger, Harlan M. Krumholz

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Although the therapeutic benefit of coronary reperfusion-fibrinolytic therapy and primary percutaneous coronary intervention (PCI)-for the treatment of acute ST elevation myocardial infarction (STEMI) in younger patients is well established, there remains considerable debate over the appropriate choice of a reperfusion strategy for elderly patients. The difficulty in choosing the optimum reperfusion strategy stems from the uncertainty surrounding the data on the efficacy of fibrinolytic therapy in the elderly. Complicating the choice of a strategy for the elderly is the increased risk of bleeding associated with fibrinolytic therapy. Although the data for safety and efficacy for primary PCI are more convincing, primary PCI is not widely available as a reperfusion option (1).

Original languageEnglish (US)
Title of host publicationPharmacoinvasive Therapy in Acute Myocardial Infarction
PublisherCRC Press
Pages209-229
Number of pages21
ISBN (Electronic)9780849340550
ISBN (Print)0824759400, 9780824759407
StatePublished - Jan 1 2005

Fingerprint Dive into the research topics of 'Considerations in reperfusion therapy of elderly patients with ST elevation acute myocardial infarction'. Together they form a unique fingerprint.

Cite this